Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1989;80:983-993

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Indolfi, C.
Right arrow Articles by Ross, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Indolfi, C.
Right arrow Articles by Ross, J., Jr

Circulation, Vol 80, 983-993, Copyright © 1989 by American Heart Association


ARTICLES

Mechanisms of improved ischemic regional dysfunction by bradycardia. Studies on UL-FS 49 in swine

C Indolfi, BD Guth, T Miura, S Miyazaki, R Schulz and J Ross Jr
Department of Medicine, University of California, San Diego, La Jolla 92093.

In anesthetized swine, the left anterior descending coronary artery was cannulated and perfused at constant blood flow levels during two grades of ischemia. In one group (n = 10), moderate ischemia reduced percent systolic wall thickening (by sonomicrometry) from 25 +/- 7% to 6 +/- 2%, whereas in the other group (n = 7), severe ischemia reduced percent wall thickening from 24 +/- 6% to -0.5 +/- 4%. Heart rate was paced in both groups at 91 beats/min. After reperfusion and complete return to control conditions, administration of the bradycardic agent UL-FS 49 (0.37 mg/kg i.v.) decreased the heart rate to 55 +/- 5 beats/min. During subsequent ischemia at the same coronary inflow as before bradycardia, percent wall thickening in the ischemic zone during moderate ischemia was increased from 6 +/- 2% to 25 +/- 6% (p less than 0.01) (not significantly different from control without ischemia), and during severe ischemia, percent wall thickening increased from -0.5 +/- 4% to 13 +/- 7% (p less than 0.01). During moderate ischemia, bradycardia caused an increase in the subendocardial blood flow from 0.24 +/- 0.60 to 0.42 +/- 0.17 (ml/min)/g (p less than 0.009) and during severe ischemia, bradycardia caused an increase from 0.14 +/- 0.08 to 0.2 +/- 0.1 (ml/min)/g (p less than 0.001). At each level of ischemia, a more marked improvement occurred in subendocardial blood flow per beat ([(ml/min)/g]/heart rate). The relation between myocardial blood flow and wall function at a heart rate of 55 beats/min (n = 14) was plotted and compared with that studied at a heart rate of 122 beats/min in another group of pigs (n = 14). The increase in subendocardial blood flow per minute during bradycardia was not sufficient to explain the striking increase in function; thus, an independent relation (p less than 0.05) between blood flow per minute and contractile function (percent wall thickening) was found for for each heart rate. In contrast, when myocardial blood flow was normalized for heart rate and expressed per beat, data from both heart rate groups could be described by a single relation. Thus, the subendocardial blood flow per beat predicted wall function independently of heart rate and accounted for changes in both oxygen supply and demand.


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
K.-i. Umehara, N. Nakada, K. Noguchi, T. Iwatsubo, T. Usui, and H. Kamimura
Investigation of Long-Term Retention of Unchanged (-)-N-{2-[(R)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide, A Novel "Funny" If Current Channel Inhibitor, and Its Metabolites in the Eyeball and Thoracic Aorta of Rats
Drug Metab. Dispos., November 1, 2009; 37(11): 2137 - 2144.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K.-i. Umehara, N. Shirai, T. Iwatsubo, K. Noguchi, T. Usui, and H. Kamimura
Identification of Human Metabolites of (-)-N-{2-[(R)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a Novel If Channel Inhibitor, and Investigation of the Transporter-Mediated Renal and Hepatic Excretion of These Metabolites
Drug Metab. Dispos., August 1, 2009; 37(8): 1646 - 1657.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K.-i. Umehara, K. Wada, K. Noguchi, T. Iwatsubo, T. Usui, and H. Kamimura
Relationship between Exposure of (-)-N-{2-[(R)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a "Funny" If Current Channel Inhibitor, and Heart Rate Reduction in Tachycardia-Induced Beagle Dogs
Drug Metab. Dispos., July 1, 2009; 37(7): 1427 - 1433.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Heusch, A. Skyschally, P. Gres, P. van Caster, D. Schilawa, and R. Schulz
Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction
Eur. Heart J., September 2, 2008; 29(18): 2265 - 2275.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K.-i. Umehara, M. Iwai, Y. Adachi, T. Iwatsubo, T. Usui, and H. Kamimura
Hepatic Uptake and Excretion of (-)-N-{2-[(R)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a Novel If Channel Inhibitor, in Rats and Humans
Drug Metab. Dispos., June 1, 2008; 36(6): 1030 - 1038.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Heusch, R. Schulz, and S. H. Rahimtoola
Myocardial hibernation: a delicate balance
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H984 - H999.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
X. Monnet, P. Colin, B. Ghaleh, L. Hittinger, J.-F. Giudicelli, and A. Berdeaux
Heart rate reduction during exercise-induced myocardial ischaemia and stunning
Eur. Heart J., April 1, 2004; 25(7): 579 - 586.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Colin, B. Ghaleh, X. Monnet, J. Su, L. Hittinger, J.-F. Giudicelli, and A. Berdeaux
Contributions of heart rate and contractility to myocardial oxygen balance during exercise
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H676 - H682.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
L. Sen, G. Cui, L.-M. Zhou, Y. Sakaguchi, and B. N. Singh
Acute Effects of Zatebradine on Cardiac Conduction and Repolarization
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2002; 7(1): 29 - 38.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Monnet, B. Ghaleh, P. Colin, O. P. de Curzon, J.-F. Giudicelli, and A. Berdeaux
Effects of Heart Rate Reduction with Ivabradine on Exercise-Induced Myocardial Ischemia and Stunning
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1133 - 1139.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. HEUSCH
Hibernating Myocardium
Physiol Rev, October 1, 1998; 78(4): 1055 - 1085.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Ross Jr, T. Miura, M. Kambayashi, G. P. Eising, and K.-H. Ryu
Adrenergic Control of the Force-Frequency Relation
Circulation, October 15, 1995; 92(8): 2327 - 2332.
[Abstract] [Full Text]


Home page
CirculationHome page
G. Ferro, C. Duilio, L. Spinelli, G. A. Liucci, F. Mazza, and C. Indolfi
Relation Between Diastolic Perfusion Time and Coronary Artery Stenosis During Stress-Induced Myocardial Ischemia
Circulation, August 1, 1995; 92(3): 342 - 347.
[Abstract] [Full Text]